These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33398065)

  • 1. Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
    Malek AE
    Br J Cancer; 2021 Mar; 124(7):1183. PubMed ID: 33398065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective: SARS-CoV-2, COVID-19 and Haematologists.
    Gale RP
    Acta Haematol; 2021; 144(2):117-121. PubMed ID: 32375142
    [No Abstract]   [Full Text] [Related]  

  • 3. The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact.
    Orchard K; Dignan FL; Lee J; Pearce R; Desai M; McFarlane E; Parkin A; Shearn P; Snowden JA
    Br J Haematol; 2021 Feb; 192(3):467-473. PubMed ID: 33474730
    [No Abstract]   [Full Text] [Related]  

  • 4. Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787.
    Blood; 2023 Jun; 141(24):3007. PubMed ID: 37318902
    [No Abstract]   [Full Text] [Related]  

  • 5. Across scales: novel insights into kidney health and disease by structural biology.
    Tomas NM; Mortensen SA; Wilmanns M; Huber TB
    Kidney Int; 2021 Aug; 100(2):281-288. PubMed ID: 33940110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
    Daniele G; Raspagliesi F; Scambia G; Pisano C; Colombo N; Frezzini S; Tognon G; Artioli G; Gadducci A; Lauria R; Ferrero A; Cinieri S; De Censi A; Breda E; Scollo P; De Giorgi U; Lissoni AA; Katsaros D; Lorusso D; Salutari V; Cecere SC; Zaccarelli E; Nardin M; Bogani G; Distefano M; Greggi S; Piccirillo MC; Fossati R; Giannone G; Arenare L; Gallo C; Perrone F; Pignata S
    Int J Gynecol Cancer; 2021 Jun; 31(6):875-882. PubMed ID: 33931498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO Blood Incompatibility Positively Affects Early Graft Function: Single-Center Retrospective Cohort Study.
    Watari S; Araki M; Wada K; Yoshinaga K; Maruyama Y; Mitsui Y; Sadahira T; Kubota R; Nishimura S; Kobayashi Y; Takeuchi H; Tanabe K; Kitagawa M; Morinaga H; Kitamura S; Sugiyama H; Wada J; Watanabe M; Watanabe T; Nasu Y
    Transplant Proc; 2021 Jun; 53(5):1494-1500. PubMed ID: 33931247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours.
    Paz-Ares L; Barlesi F; Siena S; Ahn MJ; Drilon A; Conley A; Rolfo C; Wolf J; Seto T; Doebele R; Kapre A; Chen D; McCallum S; Osborne S; Demetri G
    ESMO Open; 2021 Jun; 6(3):100113. PubMed ID: 33930659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
    Ren S; Cai Y; Hu S; Liu J; Zhao Y; Ding M; Chen X; Zhan L; Zhou X; Wang X
    Biochem Pharmacol; 2021 Jun; 188():114576. PubMed ID: 33930347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context.
    Angriman F; Ferreyro BL; Burry L; Fan E; Ferguson ND; Husain S; Keshavjee SH; Lupia E; Munshi L; Renzi S; Ubaldo OGV; Rochwerg B; Del Sorbo L
    Lancet Respir Med; 2021 Jun; 9(6):655-664. PubMed ID: 33930329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.
    Rickmann A; Paez LR; Della Volpe Waizel M; Bisorca-Gassendorf L; Schulz A; Vandebroek AC; Szurman P; Januschowski K
    PLoS One; 2021; 16(4):e0250587. PubMed ID: 33930041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
    Perrottet N; Fernández-Ruiz M; Binet I; Dickenmann M; Dahdal S; Hadaya K; Müller T; Schaub S; Koller M; Rotman S; Moll S; Hopfer H; Venetz JP; Aubert V; Bühler L; Steiger J; Manuel O; Pascual M; Golshayan D;
    PLoS One; 2021; 16(4):e0250829. PubMed ID: 33930037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune infiltrate diversity confers a good prognosis in follicular lymphoma.
    Tsakiroglou AM; Astley S; Dave M; Fergie M; Harkness E; Rosenberg A; Sperrin M; West C; Byers R; Linton K
    Cancer Immunol Immunother; 2021 Dec; 70(12):3573-3585. PubMed ID: 33929583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe type-B lactic acidosis in a patient with bilateral renal Burkitt's lymphoma.
    Salcedo Betancourt JD; Garcia Valencia OA; Becerra-Gonzales VG; Carias Martinez KG; Chapman J; Yanchenko N; Ladino MA
    Clin Nephrol Case Stud; 2021; 9():49-53. PubMed ID: 33928009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054].
    De Angelis C; Bruzzese D; Bernardo A; Baldini E; Leo L; Fabi A; Gamucci T; De Placido P; Poggio F; Russo S; Forestieri V; Lauria R; De Santo I; Caputo R; Cianniello D; Michelotti A; Del Mastro L; De Laurentiis M; Giuliano M; De Placido S; Arpino G
    ESMO Open; 2021 Apr; 6(2):100097. PubMed ID: 33926709
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-Threatening Subglottic Stenosis of Granulomatosis with Polyangiitis: A Case Report.
    An J; Song JW
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma.
    Van Dijck R; Doorduijn JK; Bromberg JEC
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Intravitreal Bevacizumab Injection for Choroidal and Orbital Metastases of Refractory Invasive Ductal Carcinoma of the Breast.
    Lin IH; Kuo BI; Liu FY
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33922137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer.
    Abuhelwa AY; Kichenadasse G; McKinnon RA; Rowland A; Hopkins AM; Sorich MJ
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.